Get started
Author

J. R. F. Corvalan

Observed names: J Corválan, J R Corvalan, J R Corvalán, J. R. F. CORVALÁN, J. R. F. Corvalán, J.R.F. CORVALAN, J.R.F. Corvalan, JRF Corvalan
OpenAlex ID: A5113627727
Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy.
1999 · X D Yang, X C Jia, et al. · PubMed · 327
Use of monoclonal antibodies for the histopathological diagnosis of human malignancy
1982 · KC Gatter, Z Abdulaziz, et al. · Journal of Clinical Pathology · 223
PDF
Antitumor properties of vindesine-monoclonal antibody conjugates
1985 · G.F. Rowland, C.A. Axton, et al. · Cancer Immunology Immunotherapy · 76
Production of an H–2-related suppressor factor by a hybrid T-cell line
1979 · M. J. TAUSSIG, J. R. F. CORVALÁN, et al. · Nature · 75
Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids
1987 · J.R.F. Corvalan, W. Smith · Cancer Immunology Immunotherapy · 45
Immune response genes controlling responsiveness to major transplantation antigens. Specific major histocompatibility complex-linked defect for antibody responses to class I alloantigens.
1982 · G W Butcher, J R Corvalán, et al. · The Journal of Experimental Medicine · 44
PDF
Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids
1987 · J.R.F. Corvalan, W. Smith, et al. · Cancer Immunology Immunotherapy · 37
Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody
1987 · J.R.F. Corvalan, W. Smith, et al. · Cancer Immunology Immunotherapy · 33
Defective monocyte accessory function due to surface sulphydryl (SH) oxidation in rheumatoid arthritis.
1984 · M J McKeown, N D Hall, et al. · PubMed Central · 33
Tumour therapy with vinca alkaloids targeted by a hybrid-hybrid monoclonal antibody recognising both CEA and vinca alkaloids
1988 · J. R. F. Corvalan, W. Smith, et al. · International Journal of Cancer · 27
Classification of Anti-CEA Monoclonal Antibodies
1984 · J.R.F. CORVALAN, C.A. AXTON, et al. · Protides of the biological fluids · 24
Primary in vitro antibody formation in the rat: partial characterization and properties of an inhibitor cell present in normal spleen
1978 · J. R. F. Corvalán, J. C. Howard · European Journal of Immunology · 12
Suppression of well-established tumour xenografts by a hybrid-hybrid monoclonal antibody and vinblastine
1990 · W. Smith, V. A. Gore, et al. · Cancer Immunology Immunotherapy · 9
Development of a dual label fluorescence technique that can be utilized to elucidate the mechanism of action of monoclonal antibody-drug conjugates.
1988 · J J Starling, N A Hinson, et al. · PubMed · 8
Production and In Vivo Characterization of a Bifunctional Antibody (IVA039.1) with Specificity for the Mouse Interleukin-2 Receptor and Vinca Alkaloids
1994 · K. KUUS-REICHEL, C.L. KNOTT, et al. · Hybridoma · 5
Affinity Purification of CEA Using an Immobilised Monoclonal Anti-CEA Antibody
1984 · R.G. SIMMONDS, W. SMITH, et al. · Protides of the biological fluids · 5
Xenogeneic monoclonal antibodies in the management of cancer: control of their in vivo immunogenicity and induction of specific unresponsiveness using an antibody-drug immunoconjugate
1991 · GB Sivolapenko, C Moreno, et al. · British Journal of Cancer · 4
PDF
T-cell hybrids as a source of antigen-specific factors.
1980 · M J Taussig, A Holliman, et al. · PubMed · 3
T helper cells required for the in vitro primary antibody response to SRBC are neither SRBC-specific nor MHC-restricted.
1984 · A J Feeney, J R Corvalan, et al. · PubMed · 2
529 5-Lipoxygenase inhibition in relation to cell movement and cancer
1983 · W. Dawson, J.R.F. Corvalan, et al. · Journal of Steroid Biochemistry
Works count: 20
Citation count: 992
H-index: 12
I10-index: 12
Year
Topic
Type